Contaminated heparin preparations, severe adverse events and the contact system

Clinical and Applied Thrombosis/Hemostasis

Volumn 14, Issue 4, 2008, Pages 489-491

  Ramacciotti, Eduardo ^a,c   Wahi, Rakesh ^b   Messmore, Harry L ^b  

^a JOBST VASCULAR CENTER   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; CHONDROITIN SULFATE; DERMATAN SULFATE; HEPARIN; HIGH MOLECULAR WEIGHT KININOGEN; KALLIKREIN; OVERSULFATED CHONDROITIN SULFATE; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANTIBODY PRODUCTION; BLEEDING; BLOOD CLOTTING; CAUSE OF DEATH; DRUG CONTAMINATION; DRUG FATALITY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; HUMAN; HYPOTENSION; IMMUNOTOXICITY; IN VIVO STUDY; LETTER; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOCYTE ACTIVATION;

ANIMALS; ANTICOAGULANTS; CHONDROITIN SULFATES; DRUG CONTAMINATION; HEPARIN; HUMANS;

EID: 51849150063     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029608324291     Document Type: Letter

References (0)